Solitary fibrous tumors (SFTs) are a rare group of spindle cell neoplasm of submesothelial origin with malignant potential and can present as hypoglycemia secondary to excess secretion of insulin‐like growth factor II (IGF‐II) from the tumor. Early diagnosis and treatment are very important in such cases to prevent hypoxic injury to the brain secondary to hypoglycemia. Here, we are presenting a case of a 45‐year‐old male patient, who presented with recurrent episodes of hypoglycemia spells, and later on, it was diagnosed that hypoglycemic spells were secondary to fibroma.
High-sensitivity cardiac troponin T (hs-cTnT) enables earlier and more sensitive detection of myocardial injury compared with conventional troponin assays. Although extensively studied in acute coronary syndrome (ACS), its role in non-ACS hospitalized populations remains less clear. In patients admitted without ACS, hs-cTnT may improve diagnostic efficiency and reduce unnecessary testing, but it may also increase detection of ambiguous troponin elevations, leading to resource overuse. Assessing its real-world impact is therefore essential. We conducted a retrospective study of 520 hospitalized patients at St Mary's General Hospital (January-May 2023). Propensity score-matched cohorts (260 hs-cTnT vs 260 cTnT) were compared; hs-cTnT use was associated with shorter length of stay (7.3 vs 10.9 days, P < 0.01), reduced echocardiography (76.9% vs 88.8%, P = 0.005), and fewer electrophysiology procedures (2.3% vs 6.5%, P = 0.033), with no group differences in mortality. Findings indicated that hs-cTnT streamlines inpatient care, reduces resource use, and maintains safety, supporting its broader adoption beyond ACS.
26 August 2026 in Pacing and Clinical Electrophysiology